BioPharmaStock
HomeAsk About StockNewsIdeasHistoryFDA DesignationsElite Program

LIPO

No price yet

Announcements

Nothing here yet

Daily updates

Nothing here yet

FDA designations

Nothing here yet

News

  • Lipella Pharmaceuticals announces positive final results from Phase 2a study of LP-10 in oral lichen planusSep 18, 2025
  • Lipella Pharmaceuticals announces U.S. patent granted for diagnostic technologyJun 18, 2025
  • Lipella Pharmaceuticals announces U.S. patent granted for diagnostic technologyJun 18, 2025
  • Lipella Pharmaceuticals to present Phase 2a data for LP-310 in oral lichen planus at 2025 AAOM/EAOM International Meeting.May 15, 2025

    Bio Pharma Stock

    Where Science Meets Investing.

    BioPharmaStock is a specialized biopharmaceutical investment intelligence company focused exclusively on publicly traded biotechnology and pharmaceutical companies. Our research team continuously analyzes clinical trials, FDA regulatory events, scientific publications, corporate developments, and market catalysts to deliver timely research and exclusive insights for investors seeking opportunities in one of the world's most knowledge-intensive sectors.

    ALNJAM ALAALI SOFTWARE DESIGN CO. L.L.C, UAE, Abu Dhabi

    BioPharmaStock LogoBioPharmaStock Logo

    Quick Links

    • Home
    • Ask About Stock
    • News
    • Ideas
    • History
    • FDA Designations
    • Elite Program

    Contact Us

    Email: info@biopharmastock.com

    Phone: +971 50 936 3328

    Join Our Community→

    Follow Us

    Get the App

    Instant notifications on your phone

    Download on theApp StoreGet it onGoogle Play

    © 2026 Bio Pharma Stock. All rights reserved. Policy